R.A. Names Flashcards
RA 10918
Philippine Pharmacy Act
RA 10912
Continuing Professional Development Act of 2016
RA 10909
No Shortchanging Act of 2016
RA 5921
The Pharmacy Law
RA 3720
Foods, Drugs, Devices, and Cosmetics Act
RA 6425
Dangerous Drugs Act of 1972
RA 6675
The Generics Act of 1988
RA 9165
Comprehensive Dangerous Drugs Act of 2002
RA 7432
The Senior Citizens Act
RA 9257
Expanded Senior Citizens Act
RA 9994
Expanded Senior Citizens Act of 2010
RA 8203
Special Law on Counterfeit Drug
RA 8981
PRC Modernization Act
RA 7581
The Price Act of 2000
RA 7394
The Consumers Act of the Philippines
RA 9711
Food and Drug Administration Act
RA 9502
Universally Accessible Cheaper and Quality Medicines Act of 2008
RA 8293
Intellectual Property Code of the Philippines
RA 8172
ASIN Law
RA 9211
Tobacco Regulation Act of 2003
RA 7876
The Senior Citizen Center Act
RA 8423
TAMA of 1997
RA 9184
Procurement Act
RA 8976
Food Fortification Law
RA 10354
The Responsible Parenthood and Reproductive Health Act of 2012
EO 174
Amendments on RA 5921
EO 175
Amendments on RA 3720
AO 2014-0034
Licensing for Drug Products
AO 2014-025
New Rules for Licensing Botica/ Drugstore/ Pharmacy
AO 2014-026
New Rules for Licensing Drug Distributors
AO 2014-027
New Rules for Licensing RONPDS
AO 2014-028
New Rules for Licensing Drug Manufacturer
AO 2016-0003
Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration
AO 2016-0008
Revised Rules and Regulations Governing the Generic Labeling Requirements of Drug Products for Human Use
AO 2015-0053
Implementing Guidelines on the Promotion and Marketing of Prescription Pharmaceutical Products and Medical Devices
AO 2013-0026
Rules and Regulations of Veterinary Drugs and Products, Veterinary Biological products and Veterinary Drugs Establishments
AO 42
Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines
AO 2011-0009
National Policy and Program on Pharmacovigilance
EO 851
Creation of BFAD
EO 266
Institutionalization of CPE
EO 302
Adoption of Philippine Pharmacopeia as the Official Book of Standards Reference for Pharmaceutical Products and Crude Plant Drugs in the Philippines
EO 49
Directing the Mandatory Use of the PNDF Volume I as the Basis for Procurement of Drug Products by the Government
EO 119
Reorganization of BFAD
PD 1926
Shortens the Pharmacy from 5 years to 4 years
PD 1363
Candidacy for Pharmacy Board Examination (Citizenship Requirement)
PD 881
Household Hazardous Substances Act
PD 223
Creation of PRC
AO 220
cGMP
AO 43
Practice Guidelines for Drugs
AO 79
Transitional Remedial Labelling
AO 42
Drug Registration of Herbal/ Traditional (Local and Imported)
AO 55
Requirements for Labelling Materials of Pharmaceutical Products
AO 64
Amendments to AO 55
AO 67
Revised Rules and Regulations of Registration of Pharmaceutical Products
AO 56
Revised Regulations for the Licensing of Drug Establishments and Drug Outlets
AO 63
IRR for Dispensing Requirements (RA 6675)
AO 62
IRR for Prescribing Requirements (RA 6675)
AO 90
Writing more than one generic name on the prescription form/ Amendments to AO 62
RA 11036
National Mental Health Policy
RA 10754
PWD
RA 10932
Anti-Hospital Deposit Law
RA 11223
Universal Health Care Law
RA 10767
Comprehensive Tuberculosis Elimination Plan Act of 2016
RA 10747
Rare Disease Act of the Philippines
RA 10643
Graphic Health Warnings Law
RA 10640
An act to further strengthen anti-drug campaign, amending section 21 of RA 9165
RA 10645
Mandatory PhilHealth Coverage
FDA No. 2014-067
FDA and PPhA Plan to Authorize Community Pharmacists to Administer Vaccine
RA 8344
Act prohibiting the demand of deposit